The study found that up to 45% of SCLC samples and 50% of cell lines exhibited ASS1-negativity, highlighting the importance of arginine biosynthesis downregulation in the progression of lung carcinogenesis (78, 79). The gene discussed is ASS1; the disease is small cell lung carcinoma.